NCT04789993 (AADT1D) is a clinical trial of No intervention. in Type 1 Diabetes, sponsored by Central Hospital, Nancy, France.

Who is sponsoring NCT04789993?

NCT04789993 is sponsored by Central Hospital, Nancy, France.

What drugs are being tested in NCT04789993?

Interventions in NCT04789993: No intervention..

What condition does NCT04789993 study?

NCT04789993 studies Type 1 Diabetes, Autoimmune Diseases, Hashimoto Disease, Graves Disease, Celiac Disease, Addison Disease, Vitiligo.

Is NCT04789993 still recruiting?

NCT04789993 is currently status unknown. Last updated 30 March 2021.

Last reviewed 2021-03-30 · How we verify

NCT04789993: AADT1D

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Additional Autoimmune Diseases With Type 1 Diabetes in Pediatrics at Diabetes Diagnosis and During Follow-up

Status unknown Last updated 30 March 2021

What this trial tests

trial testing No intervention. in Type 1 Diabetes in 250 participants. Status unknown.

Timeline

15 March 2021

Primary endpoint
31 March 2021

30 April 2021

Quick facts

Lead sponsor	Central Hospital, Nancy, France
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	250
Start date	15 March 2021
Primary completion	31 March 2021
Estimated completion	30 April 2021
Sites	1 location across France

Drugs / interventions tested

No intervention.

Conditions studied

Type 1 Diabetes — all drugs for Type 1 Diabetes →
Autoimmune Diseases — all drugs for Autoimmune Diseases →
Hashimoto Disease — all drugs for Hashimoto Disease →
Graves Disease — all drugs for Graves Disease →

Sponsor

Central Hospital, Nancy, France

Who can join

6 Months and older, any sex, with Type 1 Diabetes or Autoimmune Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to describe the prevalence of additional autoimmune diseases and their specific antibodies at type 1 diabetes (T1D) diagnosis, and their incidence rate during follow-up, for children and adolescents. It also aims to describe the characteristics of the pediatric cohort followed since 2014 for type 1 diabetes by one of France's centers of reference for paediatric diabetes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of No intervention.

Trials testing the same drug.

NCT06843863 — The Effects of Smartphone Addiction on Pinch Strength, Muscle Stiffness, and Hand/Wrist Function in Young Adults · recruiting
NCT07084883 — Pivotal Trial of an Automated AI-based System for Early Diagnosis and Prediction of Late Age-related Macular Degeneratio · recruiting
NCT06427018 — Expressions of Ezrin and Pip5k1α Proteins in Airway Smooth Muscle of Asthmatic Patients · recruiting
NCT06134739 — Arterial Embolism After Catheter Ablation of Atrial Fibrillation. ATRIAL FIBRILLATION · unknown
NCT05963126 — Fetuin A as a Predictor of Deterioration of Renal Function in Hypertonic Patients · recruiting

Other recruiting trials for Type 1 Diabetes

Currently open trials in the same condition.

NCT07061574 — A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New On · Phase 1, PHASE2 · recruiting
NCT07360080 — Long-Term Outcomes of Teplizumab in Routine Clinical Care · recruiting
NCT07457580 — Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs) · recruiting
NCT07212179 — Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 · NA · recruiting
NCT07287943 — To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes. · NA · recruiting

Other Central Hospital, Nancy, France trials

Trials by the same sponsor.

NCT06452290 — PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder · NA · not yet recruiting
NCT07518498 — Hypnosis During Mechanical Ventilation Weaning · NA · not yet recruiting
NCT07471334 — Prospective Study of Postictal Psychotic Symptoms Occuring After Video-EEG Monitoring in Focal Epilepsies · NA · not yet recruiting
NCT07414667 — Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification ( · not yet recruiting
NCT07415759 — Imaging of Electrical Properties by MRI: Investigation of Age-Related Changes · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04789993 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Central Hospital, Nancy, France
Last refreshed: 30 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04789993.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing